Precautions When Combining Digoxin and Amiodarone
When amiodarone is added to digoxin therapy, the digoxin dosage should be reduced by 50% immediately and digoxin levels should be closely monitored, as amiodarone predictably doubles serum digoxin concentrations and can lead to digoxin toxicity. 1
Mechanism of Interaction
Amiodarone significantly affects digoxin pharmacokinetics through several mechanisms:
- Inhibits digoxin secretion from renal tubules 1
- Inhibits P-glycoprotein membrane transporter system 1
- Results in approximately 100% increase in serum digoxin concentrations 1, 2
Monitoring Requirements
Initial Management
- Reduce digoxin dose by 50% when starting amiodarone 1, 3
- Monitor digoxin levels closely during the first 7-8 weeks of combination therapy 1
- Be aware that peak effects of the interaction occur approximately 7 weeks after initiation 1
Ongoing Monitoring
- Check digoxin levels every 6 months during continued combination therapy 1
- Monitor for signs and symptoms of digoxin toxicity 1, 3
- Therapeutic trough serum digoxin level should be maintained at 0.5-1.0 ng/mL 3
- Levels >2.0 ng/mL are associated with increased toxicity risk 3
Signs of Digoxin Toxicity to Monitor For
- Cardiac: bradycardia, heart block, ventricular arrhythmias
- Gastrointestinal: anorexia, nausea, vomiting
- Neurological: visual disturbances (yellow-green halos), confusion, fatigue
- Check digoxin level immediately if toxicity is suspected 3
Additional Precautions
Contraindications:
Other Drug Interactions:
Mortality Risk:
- Recent evidence suggests digoxin-amiodarone combination may be associated with increased all-cause mortality compared to digoxin alone in atrial fibrillation patients 5
Special Populations:
Clinical Decision Algorithm
Before starting combination:
- Obtain baseline digoxin level
- Assess renal function
- Check for pre-existing bradycardia or heart block
When adding amiodarone:
- Immediately reduce digoxin dose by 50%
- Monitor heart rate closely, especially during first week 1
Follow-up monitoring:
If signs of toxicity develop:
- Check digoxin level immediately
- Consider temporary discontinuation of digoxin
- For severe toxicity with levels >2.0 ng/mL, consider digoxin-specific antibody fragments 3
Wolff-Parkinson-White Syndrome Warning
In patients with WPW syndrome and pre-excited atrial fibrillation, digoxin is contraindicated as it can facilitate antegrade conduction along the accessory pathway, potentially resulting in acceleration of ventricular rate, hypotension, or ventricular fibrillation 1.